M.Pharmacy I Year II Semester (R22)
The course contents of Unit I and Unit II are mainly aimed at enzyme inhibitors for
the treatment of different CNS and CVS diseases. Unit III contents are aimed to have advanced knowledge of the developments of antipsychotic agents. The remaining contents are aimed to design prodrugs, peptidomimetic agents and recombinant DNA products.
The student would be in a position to involve in the development of different
enzyme inhibitors, prodrugs and also equipped with different biotechnological techniques of recombinant DNA products.
Enzyme Inhibitors I: A detailed study of the following types of enzyme inhibitors, related drugs and their pharmaceutical significance:
Enzyme Inhibitors II:
Antipsychotic Agents: Role of Dopamine, Serotonin, Glutamate and their receptors. SAR and Pharmacokinetics of Ticyclic Neuroleptics, Butyrophenones and Benzamides. A brief account of non – benzodiazepine agonist.
Peptidmimetic agents & Prodrugs
Biotechnologically produced drugs: Biotechnology of Recombinant DNA, Process of Recombinant proteins, Immunogencity of biotechnologically produced drugs. Recombinant drug products: Hormones, cytokinins, interferons, Interleukins, enzymes, vaccines and monoclonal antibody drugs.
RECOMMENDED BOOKS:
Loading Question Papers
Fetching data from database...